TGFB1 and cystic fibrosis: Meanwhile, it was found that NG with 40 μmol/L kirenol treatment did not significantly enhance the expression of TGF‐β1 and fibronectin in CFs and the expression of TGF‐β1 in CF supernatants compared with NG treatment.